PRTN3 and rheumatoid arthritis: Women with RA who discontinued TNFi at conception displayed a high risk of flares during pregnancy, independently of known risk factors like RF and ACPA positivity and despite remission/low disease activity at conception (p 0.003 OR 8.2, 95% Cl 2.1–33.2) (Fischer-Betz et al., 2015).